Skip to main content
. 2003 Apr;55(4):360–367. doi: 10.1046/j.1365-2125.2003.01780.x

Figure 1.

Figure 1

Mean ribavirin concentration–time profiles in the initial single-dose (a) and final multiple-dose (b) studies and steady-state phase (c) in patients treated with interferon-alpha 2b plus ribavirin combination therapy. —, Patients with sustained virological response; —, those with virological response during treatment, but without sustained virological response after cessation of treatment; ·····, patients without virological response throughout the study period.